1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Reporter Account

CRWENewswire Stock Highlights: AQNM.OB, PWRM.OB

CRWENewswire,com is pleased to announce a stock highlight on Aquentium (OTCBB: AQNM) , Power3 Medical Products, Inc. (OTCBB:PWRM)

FOR IMMEDIATE RELEASE

PRLog (Press Release) - Aug 10, 2009 -
CRWENewswire,com is pleased to announce a stock highlight on Aquentium (OTCBB: AQNM) , Power3 Medical Products, Inc. (OTCBB:PWRM)  Sign up to receive FREE Stock-PR alerts from CRWENewswire.com at http://www.crwenewswire.com/?p=2546

Aquentium (OTCBB: AQNM) announced today that the company expects to open an office in Seoul South Korea within the next 30 days. The office in Seoul South Korea will be used for the development of waste-to-energy plants throughout the country.

Aquentium has already begun its feasibility study for implementation of a waste-to-energy plant in the country of South Korea. The study is based on building a 1,000 metric ton per day waste to energy processing plant.
About Aquentium

Aquentium is a diversified company with an emphasis on green technologies. The company currently has interests in non-chemical sanitation equipment, waste-to-energy technologies, water treatment, food safety, mining, alternative energy, building materials, affordable housing, re-deployable housing, and recycling.

http://www.aquentium.com
email: ir@aquentium.com
Mark Taggatz
Aquentium
PO Box 580943
North Palm Springs, CA 92258
USA

Phone: 951-657-8832


Power3 Medical Products, Inc. (OTCBB:PWRM), (www.power3medical.com), today announced that the company’s CEO, Helen R. Park, M.S. was interviewed by the Wall Street Transcript, TWST, an on line magazine on Wednesday of last week.

Ms. Park provided a company update on the state of the clinical trials for Neurodegenerative disease diagnostic tests and for breast cancer diagnostic tests.   Specifically, she discussed the progress of the NuroPro® AD and NuroPro® PD clinical trials.  Power3 has finished Phase I and reported the results at the International Congress of Alzheimer’s Disease (ICAD) in Vienna, Austria on July 14 2009.  This was accomplished with the support of Power3’s licensee and collaborator for NuroPro, Transgenomic, Inc. Omaha, Nebraska and despite the huge impact on Power of the world economic down turn and Hurricane Ike.  Ms. Park re-structured the company by reducing the burn rate, and re-focused the commercialization on the completion of the NuroPro® Phase I clinical trials by executing the license and collaboration agreement with Transgenomic, and expanding  Power3’s Scientific Board to complement renowned neurologist, Dr. Stan Appel and provide additional expertise, representation and inroads in Alzheimer’s disease (Dr Marwan Sabbagh), Parkinson’s disease (Dr. Katerina Markopoulou), psychiatric diseases (Dr. Lourdes Bosquez), and gastro intestinal diseases (Dr. Eric Zuckerman).  Sources for additional funding via direct investment were also obtained.

About Power3 Medical Products, Inc.
Power3 Medical Products, Inc. (OTCBB:PWRM) (www.Power3Medical.com), is a leading Bio Medical company engaged in the commercialization of cancer and neurodegenerative disease biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. Power3's patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, identify protein biomarkers, and drug targets. Power3 operates a state-of-the-art CLIA certified laboratory in The Woodlands (Houston), Texas. The Company continues to evolve and enhance its IP portfolio.

Forward Looking Statement
This press release contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. With the exception of historical information contained herein, the matters discussed in this press release involve risk and uncertainties. Actual results could differ materially from those expressed in any forward-looking statement.

Contact:
Power3 Medical Products, Inc.
CEO
Helen R. Park, M.S.
hpark@power3medical.com
www.power3medical.com

About CRWENewswire.com

CRWENewswire.com is an independent electronic informative online financial news publication company dedicated in providing company associates, business and financial professionals with economic and investment information, as well as stock highlights. CRWENewswire.com is a division of Crown Equity Holdings, Inc.
CRWENewswire.com is not a registered investment advisor or broker-dealer. CRWENewswire.com and Crown Equity Holdings, Inc., (CRWE) affiliates, officers, directors, contractors and employees, including may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.
We encourage investors to join and receive CRWENewswire.com FREE e-mail news and stock watch alerts at http://www.crwenewswire.com/?p=2546 and view our full disclaimer.


THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Rule 17B requires disclosure of payment for investor relations. (Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for the completion of building a website for Power 3 Medical Products Inc. (PWRM.OB)

--- end ---

Click to Share

Contact Email:
***@crownequityholdings.com Email Verified
Source:Kenneth Bosket
Phone:7024481543
Fax:7022589007
Address:9663 St. Claude Av
Zip:89148
State/Province:Nevada
Country:United States
Industry:Business, Manufacturing, Technology
Tags:, , , , , ,
Last Updated:Aug 10, 2009
Shortcut:http://prlog.org/10306105
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Upcoming Press Releases...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
3.5K1.4K1.3K
Click to Share